NGEN-OS
Dead / Abandoned — Abandoned — no statement of use filed (as of 02 Oct 2023)
What this means for you
This application is over — abandoned 02 Oct 2023. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 90398276
- Mark type
- Stylized text
- Filed
- 21 Dec 2020
- Published for opposition
- 05 Jul 2022
- Abandoned
- 02 Oct 2023
- Attorney of record
- Christina M. Licursi
Goods and services
- Class 042 — Scientific and technological services: Research and development in the field of computational biology, bioinformatics, biotechnology and pharmaceuticals; none of the foregoing relating to human growth hormones, mutation detection reagents, genome editing reagents, polynucleotide assembly reagents, or endocrine diseases and disorders
Owner
- Omega Therapeutics, Inc., Cambridge, MA, US
- Omega Therapeutics, Inc., Cambridge, MA, US
Prosecution history
- 02 Oct 2023 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 02 Oct 2023 — ABANDONMENT - NO USE STATEMENT FILED
- 01 Jun 2023 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 01 Jun 2023 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 01 Jun 2023 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 28 Feb 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 24 Feb 2023 — SOU EXTENSION 1 GRANTED
- 24 Feb 2023 — SOU EXTENSION 1 FILED
- 24 Feb 2023 — SOU TEAS EXTENSION RECEIVED
- 30 Aug 2022 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 05 Jul 2022 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 05 Jul 2022 — PUBLISHED FOR OPPOSITION
- 15 Jun 2022 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 01 Jun 2022 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 24 May 2022 — TEAS/EMAIL CORRESPONDENCE ENTERED